Multi-omics and machine learning in cholangiocarcinoma: A paradigm shift toward molecular subtyping and precision therapy. Xu M, Ju-Seog L. Hepatology 2025 Oct 2. doi: 10.1097/HEP.0000000000001560.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu M, Ju-Seog L. Multi-omics and machine learning in cholangiocarcinoma: A paradigm shift toward molecular subtyping and precision therapy. Hepatology 2025 Oct 2. doi: 10.1097/HEP.0000000000001560.
PMID: 41037731